These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Prevalence of newly diagnosed sarcoidosis in patients with ventricular arrhythmias: a cardiac magnetic resonance and 18F-FDG cardiac PET study. Kebed KY, Carter SV, Flatley E, Ward RP, Moss JD, Appelbaum DE, Singh A, Lang RM, Tung R, Patel AR. Int J Cardiovasc Imaging; 2021 Apr; 37(4):1361-1369. PubMed ID: 33225427 [Abstract] [Full Text] [Related]
4. Diagnostic accuracy and prognostic value of simultaneous hybrid 18F-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging in cardiac sarcoidosis. Wicks EC, Menezes LJ, Barnes A, Mohiddin SA, Sekhri N, Porter JC, Booth HL, Garrett E, Patel RS, Pavlou M, Groves AM, Elliott PM. Eur Heart J Cardiovasc Imaging; 2018 Jul 01; 19(7):757-767. PubMed ID: 29319785 [Abstract] [Full Text] [Related]
5. Comparison of (18)F-fluorodeoxyglucose positron emission tomography (FDG PET) and cardiac magnetic resonance (CMR) in corticosteroid-naive patients with conduction system disease due to cardiac sarcoidosis. Ohira H, Birnie DH, Pena E, Bernick J, Mc Ardle B, Leung E, Wells GA, Yoshinaga K, Tsujino I, Sato T, Manabe O, Oyama-Manabe N, Nishimura M, Tamaki N, Dick A, Dennie C, Klein R, Renaud J, deKemp RA, Ruddy TD, Chow BJW, Davies R, Hessian R, Liu P, Beanlands RSB, Nery PB. Eur J Nucl Med Mol Imaging; 2016 Feb 01; 43(2):259-269. PubMed ID: 26359191 [Abstract] [Full Text] [Related]
6. Diagnostic utility of fusion 18F-fluorodeoxyglucose positron emission tomography/cardiac magnetic resonance imaging in cardiac sarcoidosis. Okune M, Yasuda M, Soejima N, Kagioka Y, Kakehi K, Kawamura T, Hanaoka K, Kaida H, Ishii K, Nakazawa G, Miyazaki S, Iwanaga Y. J Nucl Cardiol; 2022 Apr 01; 29(2):753-764. PubMed ID: 33000410 [Abstract] [Full Text] [Related]
7. Hybrid Magnetic Resonance Imaging and Positron Emission Tomography With Fluorodeoxyglucose to Diagnose Active Cardiac Sarcoidosis. Dweck MR, Abgral R, Trivieri MG, Robson PM, Karakatsanis N, Mani V, Palmisano A, Miller MA, Lala A, Chang HL, Sanz J, Contreras J, Narula J, Fuster V, Padilla M, Fayad ZA, Kovacic JC. JACC Cardiovasc Imaging; 2018 Jan 01; 11(1):94-107. PubMed ID: 28624396 [Abstract] [Full Text] [Related]
11. Diagnosis of cardiac sarcoidosis in patients presenting with cardiac arrest or life-threatening arrhythmias. Hatipoglu S, Gardezi SKM, Azzu A, Baksi J, Alpendurada F, Izgi C, Khattar R, Kouranos V, Wells AU, Sharma R, Wechalekar K, Pennell DJ, Mohiaddin R. Heart; 2023 Apr 25; 109(10):748-755. PubMed ID: 36627181 [Abstract] [Full Text] [Related]
12. Regional myocardial damage and active inflammation in patients with cardiac sarcoidosis detected by non-invasive multi-modal imaging. Kataoka S, Momose M, Fukushima K, Serizawa N, Suzuki A, Kondo C, Abe K, Sakai S, Hagiwara N. Ann Nucl Med; 2017 Feb 25; 31(2):135-143. PubMed ID: 27804054 [Abstract] [Full Text] [Related]
13. The prognostic role of cardiac positron emission tomography imaging in patients with sarcoidosis: A systematic review. Ahmed AI, Abebe AT, Han Y, Alnabelsi T, Agrawal T, Kassi M, Aljizeeri A, Taylor A, Tleyjeh IM, Al-Mallah MH. J Nucl Cardiol; 2021 Aug 25; 28(4):1545-1552. PubMed ID: 34228337 [Abstract] [Full Text] [Related]